Atlas Venture Life Science Advisors, LLC Ikena Oncology, Inc. Put Options Transaction History
Atlas Venture Life Science Advisors, LLC
- $799 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IKNA
# of Institutions
60Shares Held
32MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA4.77MShares$7.77 Million0.2% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.89MShares$6.34 Million1.46% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.77 Million0.11% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.67 Million3.31% of portfolio
-
Chi Advisors LLC New York, NY2.18MShares$3.55 Million4.65% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $59.1M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...